EPAS1 and malignant endocrine neoplasm: Even though several mutations such as VHL, SDHx, EPAS1 and EGLN1 are associated with endocrine tumor initiation, many of these mutations directly or indirectly lead to stabilization of HIFs and consequently triggering the hypoxia pathway.